Evolus Inc (EOLS)
13.60
-0.10
(-0.69%)
USD |
NASDAQ |
May 17, 16:00
13.60
0.00 (0.00%)
After-Hours: 20:00
Evolus Enterprise Value: 874.55M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 17, 2024 | 874.55M |
May 16, 2024 | 881.44M |
May 15, 2024 | 852.64M |
May 14, 2024 | 823.21M |
May 13, 2024 | 813.20M |
May 10, 2024 | 821.96M |
May 09, 2024 | 845.75M |
May 08, 2024 | 853.89M |
May 07, 2024 | 863.91M |
May 06, 2024 | 862.03M |
May 03, 2024 | 856.40M |
May 02, 2024 | 851.17M |
May 01, 2024 | 813.61M |
April 30, 2024 | 760.41M |
April 29, 2024 | 756.65M |
April 26, 2024 | 739.12M |
April 25, 2024 | 741.00M |
April 24, 2024 | 743.51M |
April 23, 2024 | 756.02M |
April 22, 2024 | 757.28M |
April 19, 2024 | 745.38M |
April 18, 2024 | 747.26M |
April 17, 2024 | 752.27M |
April 16, 2024 | 777.93M |
April 15, 2024 | 767.92M |
Date | Value |
---|---|
April 12, 2024 | 780.44M |
April 11, 2024 | 817.99M |
April 10, 2024 | 818.92M |
April 09, 2024 | 851.30M |
April 08, 2024 | 851.92M |
April 05, 2024 | 849.43M |
April 04, 2024 | 859.40M |
April 03, 2024 | 869.36M |
April 02, 2024 | 880.57M |
April 01, 2024 | 880.26M |
March 31, 2024 | 895.51M |
March 28, 2024 | 918.49M |
March 27, 2024 | 918.49M |
March 26, 2024 | 909.26M |
March 25, 2024 | 906.19M |
March 22, 2024 | 906.80M |
March 21, 2024 | 905.57M |
March 20, 2024 | 915.41M |
March 19, 2024 | 917.26M |
March 18, 2024 | 918.49M |
March 15, 2024 | 912.34M |
March 14, 2024 | 922.79M |
March 13, 2024 | 920.95M |
March 12, 2024 | 873.95M |
March 11, 2024 | 869.31M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
80.71M
Minimum
Mar 16 2020
922.79M
Maximum
Mar 14 2024
445.35M
Average
472.92M
Median
Enterprise Value Benchmarks
Viatris Inc | 29.86B |
Shockwave Medical Inc | 12.10B |
Perspective Therapeutics Inc | 817.27M |
Electromed Inc | 130.07M |
Xtant Medical Holdings Inc | 116.32M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -13.11M |
Revenue (Quarterly) | 59.33M |
Total Expenses (Quarterly) | 66.68M |
EPS Diluted (Quarterly) | -0.22 |
Gross Profit Margin (Quarterly) | 69.55% |
Profit Margin (Quarterly) | -22.09% |
Earnings Yield | -7.65% |
Normalized Earnings Yield | -7.653 |